Biotech | October 26, 2021
10x Genomics opens Singapore manufacturing hub
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
The BLA is being submitted under the accelerated approval pathway and is primarily based on clinical, biomarker and safety data from the Phase 2b clinical trial in people with early AD and confirmed amyloid pathology
Floods had forced the plans in Mahad to shut down
The product can be used by any lab that conducts NGS testing, making precision medicine accessible to all cancer patients
In addition to supporting the ongoing development of the first IND-approved product in clinical trials, the proceeds will also be used to expand the 3D printed drug product pipeline
Revenues from operations for FY21 stood at Rs. 202.38 crore as compared to 167.27 crore, up by 21%
The company has registered total income of Rs. 3,847 crores for Q4 FY21, up by 3% on a y-o-y basis from Rs. 3,752 crores registered during corresponding period of the previous year
The company's business in India geography posted strong growth during the quarter as it grew by 20% on a y-o-y basis and registered revenues of Rs. 1,643 crore.
Subscribe To Our Newsletter & Stay Updated
